First Trust Advisors LP Actinium Pharmaceuticals, Inc. Transaction History

First Trust Advisors LP

  • $95.8 Billion
  • Q1 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$5.76 - $9.67 $295,332 - $495,809
-51,273 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$7.01 - $8.63 $108,879 - $134,041
15,532 Added 43.46%
51,273 $406,000
Q1 2021

May 14, 2021
BUY
$7.62 - $9.79 $21,861 - $28,087
2,869 Added 8.73%
35,741 $272,000
Q4 2020

Feb 02, 2021
SELL
$7.8 - $12.64 $11,551 - $18,719
-1,481 Reduced 4.31%
32,872 $256,000
Q3 2020

Nov 05, 2020
BUY
$7.26 - $18.0 $249,402 - $618,354
34,353 New
34,353 $333,000

Others Institutions Holding ATNM

# of Institutions
72
Shares Held
6.65M
Call Options Held
369K
Put Options Held
148K
View Full List

About Actinium Pharmaceuticals, Inc.

ATNM Quotes by TradingView
  • Ticker ATNM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,184,700
  • Market Cap $186M
  • Description
  • Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly re...
More about ATNM
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email